Molecular You/ Latest News/ Molecular You Joins Capital Factory’s Health Supernova Expo
Article by Molecular You staff
06/10/2025
With just one blood test, Molecular You measures over 250 biomarkers, delivering more powerful and comprehensive data for preventive and precision medicine
Austin, Texas & Vancouver, B.C. – June 10, 2025 – Molecular You, a leader in molecular medicine and preventive health, will showcase its newly launched U.S.-wide direct-to-consumer testing platform at Health Supernova in Austin on June 12, 2025, as part of the Innovation Expo at Capital Factory.
Health Supernova is Capital Factory’s flagship biotech event, connecting innovators across Texas to focus on improving the patient experience. Capital Factory has been the most active early-stage investor in Texas since 2010, according to Pitchbook.
Molecular You tracks 250+ biomarkers across all major health systems through a single blood test, making it easy to capture and consistently track a more comprehensive picture of health and disease risk. It also offers actionable lifestyle recommendations to guide personalized, preventive health management direction and to monitor progress.
“Most diagnostic tests give you fragmented data from multiple, often inconsistently taken tests that cannot be correlated to see the system as a whole, ” said Jim Kean, CEO of Molecular You. “We can measure each of the metabolic, cardiovascular, cognitive, immune, and inflammatory systems with one easy blood test. Complex conditions like Alzheimer’s, PCOS, and autoimmune diseases, for example, are correlated to multiple biomarkers which are traditionally measured individually.”
Molecular You has accurately detected stage 1 pancreatic cancer in a symptom-free 60-year-old woman, enabling early intervention and successful removal without further treatment.
“Most diagnostics tell you what’s already gone wrong, but by measuring the underlying biochemical pathways that underpin and drive disease, we’re making it possible to get ahead of disease instead of reacting to it,” said Molecular You’s Chief Medical Officer, Dr. Murdoc Khaleghi. “We focus on using advanced biomarkers that traditional diagnostic labs don’t offer and that top longevity physicians rely on.”
Molecular You recently launched its direct-to-consumer testing platform across the United States. Pricing starts at $ 1,099 USD. To learn more or book your assessment, visit MolecularYou.com
See a demonstration of the platform, speak to the team:
-##-
About Molecular You
Molecular You empowers individuals and clinicians with a single blood test that reveals over 250 biomarkers using advanced proteomics and metabolomics. Its AI-powered platform delivers personalized risk assessments and actionable recommendations for 26+ health conditions to support longevity, chronic disease management, and early disease prevention. Clinical practices increasingly leverage Molecular You to maximize patient outcomes through predictive, preventive, and precision medicine. Learn more: https://www.molecularyou.com/